Standardization of Immune Monitoring – phase II / CIP working group

01.06.2013 bis 30.04.2017

The interpretation of the results obtained from immunological monitoring of clinical trials is a difficult task due to the variety of methods and protocols available to detect vaccine-specific T-cell responses. There is a clear need to ensure that the results generated by the tests are reproducible and sensitive, independently of the place where they have been performed.
This has led to the creation of the “CIMT Immunoguiding Program” (CIP) society which has reached a high degree of acceptance within the scientific community